Kevin M. Miller, MD, is a full professor and the Kolokotrones Chair in Ophthalmology at the David Geffen School of Medicine at UCLA, Chief of the Cataract and Refractive Surgery Division, and a member of the Stein Eye Institute.

He received his undergraduate training in electrical engineering at the Johns Hopkins University GWC Whiting School of Engineering. Working for the US Naval Research Laboratory, he developed a facility for testing the Cesium atomic clocks used in Global Positioning System satellites under space flight conditions. He received his medical training at the Johns Hopkins University School of Medicine. This was followed by an internship in Baltimore at the Franklin Square Hospital Center and a research fellowship in Ophthalmic Optics at the Wilmer Eye Institute. He received his residency training at the UCLA Stein Eye Institute and joined the full time faculty at UCLA in 1991. His clinical practice is devoted to cataract surgery, laser refractive surgery, and the rehabilitation of eyes with complex anterior segment surgical problems.

Dr. Miller is the recipient of four endowed cataract research funds at UCLA including the Paul Vicari fund, the Pat and Joe Yzurdiaga fund, the Albert Sarnoff fund, and the Amalia Simon Roth fund. He received the Honor, Senior Honor, and Secretariat awards of the American Academy of Ophthalmology (AAO). He is a member of numerous professional organizations including the American Society of Cataract and Refractive Surgery (ASCRS), the European Society of Cataract and Refractive Surgery (ESCRS), and the International Intra-Ocular Implant Club (IIIC).

Dr. Miller’s teaching activities span the range of training from undergraduate student to practicing ophthalmologist. He supervises research projects taken on by undergraduates at UCLA. He is an instructor in several required and elective medical school courses and has been involved in resident, national fellow, and international fellow training at the Stein Eye Institute for over 20 years. He served on the AAO Basic and Clinical Science Course committee for 10 years, editing 3 editions of the Clinical Optics textbook. He served on the AAO Anterior Segment Preferred Practice Patterns committee, editing two editions of Cataract in the Adult Eye. He served on the AAO Maintenance of Certification committee and the Compass committee, developing educational content for practicing ophthalmologists and materials for the One Network.  He currently serves on the AAO Program Planning committee, the Skills Transfer Advisory committee, and the EyeNet Editorial Board. For the ASCRS, he serves on the Cataract Clinical committee, the Retina Clinical committee, and the Skills Transfer Advisory committee. He writes a regular column for EyeWorld, an ASCRS publication. He was an organizer of the cataract sections for the 2012 and 2014 World Congresses of Ophthalmology. He serves on the editorial boards of the American Journal of Ophthalmology, Cataract and Refractive Surgery Today, and Em Foco, a Brazilian language publication. He is a reviewer for many ophthalmic journals. He has delivered approximately 200 invited lectures at international meetings and approximately 500 lectures at domestic meetings. He has organized approximately 90 instructional courses for residents, fellows, and practicing ophthalmologists.

Dr. Miller’s research interests span the areas of cataract surgery, cataract surgery instrumentation, intraocular lenses, ophthalmic optics, artificial iris devices, and surgical outcomes. He was an investigator in the Alcon Laboratories T3-T5 toric intraocular lens trial, the post-market approval study of the T6-T9 lenses, the Hoya Surgical Optics single-piece acrylic lens trial, and the Ophtec endocapsular tension ring trial. He participated in the development and national launch of the Alcon Laboratories Infiniti Vision phacoemulsification system. He is an investigator for the Calhoun Vision light adjustable lens. He was an investigator in the Ophtec model 311 iris reconstruction lens trial and he holds an investigational device exemption from the U.S. Food and Drug Administration to implant Morcher artificial iris devices in eyes with congenital or acquired iris defects. He is also an investigator for the ongoing HumanOptics artificial iris clinical trial.